Clinical Trials Logo

Clinical Trial Summary

This is a retrospective, observational, non-interventional drug study using de-identified data from two administrative claims datasets. The study design and analysis will reflect the perspective of the commercially insured. The objectives of this study are twofold:

1. To compare the rates of re-hospitalization among patients treated with either linezolid orally or IV, or vancomycin IV for complicated skin and skin structure infections (cSSSI) or pneumonia hospitalization.

2. To compare the total direct medical costs of patients treated with linezolid orally or IV, or vancomycin IV for cSSSI or pneumonia hospitalization.


Clinical Trial Description

A sampling method is not used in this study since it is a retrospective, non-interventional claims database analysis. Pre-specified inclusion/exclusion criteria and ICD-9, NDC, HCPC codes are applied to identify the study cohorts. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01363271
Study type Observational
Source Pfizer
Contact
Status Completed
Phase Phase 4
Start date May 2011
Completion date May 2012

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04488510 - Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Completed NCT02598609 - SEPREVEN: a Stepped-wedge Randomised Controlled Trial N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT06162455 - High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB N/A
Terminated NCT01897792 - Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma Phase 2
Recruiting NCT00842478 - Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia Phase 2/Phase 3
Completed NCT00610324 - Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients Phase 4
Completed NCT04279873 - Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
Completed NCT03303937 - Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients N/A
Recruiting NCT01796717 - Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia Phase 2/Phase 3
Recruiting NCT06170372 - High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia N/A
Completed NCT00829842 - Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery Phase 3
Recruiting NCT06261827 - High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB N/A
Completed NCT05928208 - The Role of Point-of-care Polymerase Chain Reaction in Managing Nosocomial Pneumonia
Completed NCT02793141 - International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE)
Completed NCT00236834 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization Phase 3
Not yet recruiting NCT06310941 - Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection N/A
Completed NCT02413242 - Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
Recruiting NCT04223752 - Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036) Phase 1